EXPERIENCES WITH PRICE COMPETITION OF BIOSIMILAR DRUGS IN HUNGARY

被引：0

作者：

Hornyak, L. ^{[1
]}

Nagy, Z. ^{[2
]}

Talos, Z. ^{[1
]}

Agoston, I ^{[2
]}

Endrei, D. ^{[2
]}

Csakvari, T. ^{[3
]}

Boncz, I ^{[4
]}

机构：

[1] Csolnoky Ferenc Hosp, Veszprem, Hungary

[2] Univ Pecs, Pecs, Hungary

[3] Univ Pecs, Zalaegerszeg, Hungary

[4] Univ Pecs, Fac Hlth Sci, Pecs, Hungary

来源：

关键词：

D O I：

10.1016/j.jval.2014.08.1018

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PHP83

引用

页码：A418 / A418

页数：1

共 50 条

[31] Biosimilar drugs: how safe are they?
Montoto, Silvia
LEUKEMIA & LYMPHOMA, 2019, 60 (14) : 3343 - 3344
[32] Bills target biosimilar drugs
Wadman, Meredith
NATURE, 2009, 458 (7237) : 394 - 395
[33] Bills target biosimilar drugs
Meredith Wadman
Nature, 2009, 458 : 394 - 395
[34] Biosimilar competition: lessons from Europe
Grabowski, Henry
Guha, Rahul
Salgado, Maria
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (02) : 99 - 100
[35] Biosimilar competition: lessons from Europe
Henry Grabowski
Rahul Guha
Maria Salgado
Nature Reviews Drug Discovery, 2014, 13 : 99 - 100
[36] Biosimilar drugs, myths and reality
Hernandez-Garcia, Cesar
REUMATOLOGIA CLINICA, 2014, 10 (06): : 351 - 352
[37] US biosimilar pathway: New route to biosimilar biologic drugs
Berks, Andrew
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[38] Biosimilar drugs - Concerns and opportunities
Genazzani, Armando A.
Biggio, Giovanni
Caputi, Achille Patrizio
Del Tacca, Mario
Drago, Filippo
Fantozzi, Roberto
Canonico, Pier Luigi
BIODRUGS, 2007, 21 (06) : 351 - 356
[39] Price competition or price leadership
Makoto Yano
Takashi Komatsubara
Economic Theory, 2018, 66 : 1023 - 1057
[40] Price competition or price leadership
Yano, Makoto
Komatsubara, Takashi
ECONOMIC THEORY, 2018, 66 (04) : 1023 - 1057